BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1514176)

  • 1. Thromboembolic disease--critical evaluation of laboratory investigation.
    Malm J; Laurell M; Nilsson IM; Dahlbäck B
    Thromb Haemost; 1992 Jul; 68(1):7-13. PubMed ID: 1514176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of inherited triple deficiency in a large kindred with thrombotic diathesis and deficiencies of antithrombin III, heparin cofactor II, protein C and protein S.
    Jobin F; Vu L; Lessard M
    Thromb Haemost; 1991 Sep; 66(3):295-9. PubMed ID: 1836072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study).
    Mateo J; Oliver A; Borrell M; Sala N; Fontcuberta J
    Thromb Haemost; 1997 Mar; 77(3):444-51. PubMed ID: 9065991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.
    Gladson CL; Scharrer I; Hach V; Beck KH; Griffin JH
    Thromb Haemost; 1988 Feb; 59(1):18-22. PubMed ID: 2966450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory identification of conditions predisposing to thrombosis.
    Sanfelippo MJ; Caya JG
    Wis Med J; 1990 Nov; 89(11):635-8. PubMed ID: 2148045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential role of primary hypercoagulability and antiphospholipid antibody as a risk factor of acute pulmonary thromboembolism].
    Tokuyama K; Kiuchi K; Nejima J; Takayama M; Takano T; Hayakawa H
    J Cardiol; 1998 Oct; 32(4):263-8. PubMed ID: 9833233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemostasis parameters in 55 patients with venous and/or arterial thromboembolisms].
    Thommen D; Buhrfeind E; Felix R; Sulzer I; Furlan M; Lämmle B
    Schweiz Med Wochenschr; 1989 Apr; 119(16):493-9. PubMed ID: 2524096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercoagulable states in arterial thromboembolism.
    Eason JD; Mills JL; Beckett WC
    Surg Gynecol Obstet; 1992 Mar; 174(3):211-5. PubMed ID: 1542837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of thrombophilia detected in Chinese patients with venous thrombosis.
    Liu HW; Kwong YL; Bourke C; Lam CK; Lie AK; Wei D; Chan LC
    Thromb Haemost; 1994 Apr; 71(4):416-9. PubMed ID: 8052955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
    Tomás JF; Alberca I; Tabernero MD; Cordero M; Del Pino-Montes J; Vicente V
    J Rheumatol; 1998 Jan; 25(1):57-62. PubMed ID: 9458203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria.
    Cosio FG; Harker C; Batard MA; Brandt JT; Griffin JH
    J Lab Clin Med; 1985 Aug; 106(2):218-22. PubMed ID: 3160800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study.
    Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J
    Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
    Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent thromboembolism disclosing protein C deficiency. Apropos of a case with familial investigation].
    Jonot F; Pouchelon E; Cambus JP; Bierme R; Leophonte P
    Rev Pneumol Clin; 1990; 46(5):221-4. PubMed ID: 2075365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.